D
Ginkgo Bioworks Holdings, Inc.
DNA · NYSE · Healthcare · 444M
Closing price
$13.00
+14.64% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.4×
Enterprise value / EBITDAEV/EBITDA
-3.9×
Free cash flow yieldFCF yield
-24.8%
Return on equityROE
-61.5%
Operating margin
-185.3%
Net debt / EBITDAbalance-sheet strength
-1.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.